These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 1495560)

  • 1. Human general transcription factor IIH phosphorylates the C-terminal domain of RNA polymerase II.
    Lu H; Zawel L; Fisher L; Egly JM; Reinberg D
    Nature; 1992 Aug; 358(6388):641-5. PubMed ID: 1495560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of TFIIH ATPase and kinase activities by TFIIE during active initiation complex formation.
    Ohkuma Y; Roeder RG
    Nature; 1994 Mar; 368(6467):160-3. PubMed ID: 8166891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced processivity of RNA polymerase II triggered by Tat-induced phosphorylation of its carboxy-terminal domain.
    Parada CA; Roeder RG
    Nature; 1996 Nov; 384(6607):375-8. PubMed ID: 8934526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of nematode TFIIE function reveal a link between Ser-5 phosphorylation of RNA polymerase II and the transition from transcription initiation to elongation.
    Yamamoto S; Watanabe Y; van der Spek PJ; Watanabe T; Fujimoto H; Hanaoka F; Ohkuma Y
    Mol Cell Biol; 2001 Jan; 21(1):1-15. PubMed ID: 11113176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation of C-terminal domain of RNA polymerase II is not required in basal transcription.
    Serizawa H; Conaway JW; Conaway RC
    Nature; 1993 May; 363(6427):371-4. PubMed ID: 8497323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basal components of the transcription apparatus (RNA polymerase II, TATA-binding protein) contain activation domains: is the repetitive C-terminal domain (CTD) of RNA polymerase II a "portable enhancer domain"?
    Seipel K; Georgiev O; Gerber HP; Schaffner W
    Mol Reprod Dev; 1994 Oct; 39(2):215-25. PubMed ID: 7826625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure and functional properties of human general transcription factor IIE.
    Peterson MG; Inostroza J; Maxon ME; Flores O; Admon A; Reinberg D; Tjian R
    Nature; 1991 Dec; 354(6352):369-73. PubMed ID: 1956398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation of the C-terminal domain of RNA polymerase II plays central roles in the integrated events of eucaryotic gene expression.
    Hirose Y; Ohkuma Y
    J Biochem; 2007 May; 141(5):601-8. PubMed ID: 17405796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cDNA encoding RAP74, a general initiation factor for transcription by RNA polymerase II.
    Finkelstein A; Kostrub CF; Li J; Chavez DP; Wang BQ; Fang SM; Greenblatt J; Burton ZF
    Nature; 1992 Jan; 355(6359):464-7. PubMed ID: 1734284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation of RNA polymerase by the murine homologue of the cell-cycle control protein cdc2.
    Cisek LJ; Corden JL
    Nature; 1989 Jun; 339(6227):679-84. PubMed ID: 2662013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylation of the carboxy-terminal repeat domain in RNA polymerase II by cyclin-dependent kinases is sufficient to inhibit transcription.
    Gebara MM; Sayre MH; Corden JL
    J Cell Biochem; 1997 Mar; 64(3):390-402. PubMed ID: 9057097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Medicago CDKC;1-CYCLINT;1 kinase complex phosphorylates the carboxy-terminal domain of RNA polymerase II and promotes transcription.
    Fülöp K; Pettkó-Szandtner A; Magyar Z; Miskolczi P; Kondorosi E; Dudits D; Bakó L
    Plant J; 2005 Jun; 42(6):810-20. PubMed ID: 15941395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcription. The tell-tail trigger.
    Peterson MG; Tjian R
    Nature; 1992 Aug; 358(6388):620-1. PubMed ID: 1495558
    [No Abstract]   [Full Text] [Related]  

  • 14. An oligomeric form of the large subunit of transcription factor (TF) IIE activates phosphorylation of the RNA polymerase II carboxyl-terminal domain by TFIIH.
    Serizawa H; Conaway JW; Conaway RC
    J Biol Chem; 1994 Aug; 269(32):20750-6. PubMed ID: 8051177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heat-shock inactivation of the TFIIH-associated kinase and change in the phosphorylation sites on the C-terminal domain of RNA polymerase II.
    Dubois MF; Vincent M; Vigneron M; Adamczewski J; Egly JM; Bensaude O
    Nucleic Acids Res; 1997 Feb; 25(4):694-700. PubMed ID: 9016617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation of RNA polymerase IIA occurs subsequent to interaction with the promoter and before the initiation of transcription.
    Laybourn PJ; Dahmus ME
    J Biol Chem; 1990 Aug; 265(22):13165-73. PubMed ID: 2376591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. hnRNP U inhibits carboxy-terminal domain phosphorylation by TFIIH and represses RNA polymerase II elongation.
    Kim MK; Nikodem VM
    Mol Cell Biol; 1999 Oct; 19(10):6833-44. PubMed ID: 10490622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoter-proximal stalling results from the inability to recruit transcription factor IIH to the transcription complex and is a regulated event.
    Kumar KP; Akoulitchev S; Reinberg D
    Proc Natl Acad Sci U S A; 1998 Aug; 95(17):9767-72. PubMed ID: 9707550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interaction of RNA polymerase II with the adenovirus-2 major late promoter is precluded by phosphorylation of the C-terminal domain of subunit IIa.
    Chesnut JD; Stephens JH; Dahmus ME
    J Biol Chem; 1992 May; 267(15):10500-6. PubMed ID: 1316903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of RNA polymerase II elongation potential by a novel carboxyl-terminal domain kinase.
    Marshall NF; Peng J; Xie Z; Price DH
    J Biol Chem; 1996 Oct; 271(43):27176-83. PubMed ID: 8900211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.